Eupraxia Pharmaceuticals Quote - EPRX

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

4.60

Bid

4.60

Offer

4.63

Volume

21,047

4.48 Day's Range 4.61

3.07 52 Week Range 7.64

Market Cap

125.497M

Previous Close

4.49

Open

4.48

Last Trade

100

4.6

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

15,820

Shares Outstanding

27,282,000

Dividend Yield

PE Ratio

-4.46

Earnings Per Share (EPS)

-1.03

Revenue

Net Profit

-28.22M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eupraxiapharma.com

Headquarters

Victoria, British Columbia, Can

Founded

Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $4.49. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 3.07 to $ 7.64.

Eupraxia Pharmaceuticals currently has 27,282,000 shares in issue. The market capitalisation of Eupraxia Pharmaceuticals is $122.50 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.46.

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months Canada NewsWire VICTORIA, BC, Nov. 20, 2024...

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting Canada NewsWire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /CNW/ - Eupraxia...

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis Canada NewsWire VICTORIA, BC, Nov. 12, 2024...

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire VICTORIA, BC, Nov. 7, 2024 VICTORIA, BC, Nov. 7, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.2	4.54545454545	4.4	4.61	4.26	15527	4.42814051	CS
4	0.27	6.23556581986	4.33	4.7	4.13	13704	4.41960368	CS
12	0.31	7.22610722611	4.29	5.45	4.1	15820	4.60819007	CS
26	1.2	35.2941176471	3.4	5.45	3.07	22660	4.0821916	CS
52	-2.15	-31.8518518519	6.75	7.64	3.07	31812	4.21506649	CS
156	2.59	128.855721393	2.01	9.1	0.8	27609	4.3157947	CS
260	-3.15	-40.6451612903	7.75	9.1	0.8	24569	4.23362074	CS

EPRX - Frequently Asked Questions (FAQ)

What is the current Eupraxia Pharmaceuticals share price?

The current share price of Eupraxia Pharmaceuticals is $ 4.60

How many Eupraxia Pharmaceuticals shares are in issue?

Eupraxia Pharmaceuticals has 27,282,000 shares in issue

What is the market cap of Eupraxia Pharmaceuticals?

The market capitalisation of Eupraxia Pharmaceuticals is CAD 122.5M

What is the 1 year trading range for Eupraxia Pharmaceuticals share price?

Eupraxia Pharmaceuticals has traded in the range of $ 3.07 to $ 7.64 during the past year

What is the PE ratio of Eupraxia Pharmaceuticals?

The price to earnings ratio of Eupraxia Pharmaceuticals is -4.46

What is the reporting currency for Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals reports financial results in USD

What is the latest annual profit for Eupraxia Pharmaceuticals?

The latest annual profit of Eupraxia Pharmaceuticals is USD -28.22M

What is the registered address of Eupraxia Pharmaceuticals?

The registered address for Eupraxia Pharmaceuticals is 201 - 2067 CADBORO BAY ROAD, VICTORIA, BRITISH COLUMBIA, V8R 5G4.

What is the Eupraxia Pharmaceuticals website address?

The website address for Eupraxia Pharmaceuticals is www.eupraxiapharma.com

Which industry sector does Eupraxia Pharmaceuticals operate in?

Eupraxia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BNGBengal Energy Ltd	$ 0.01 (100.00%)	46.6k
CTSConverge Technology Solutions Corp	$ 5.42 (53.54%)	14.22M
RTGRTG Mining Inc	$ 0.03 (20.00%)	86k
WLLWWillow Biosciences Inc	$ 0.03 (20.00%)	2.4k
AMCArizona Metals Corp	$ 1.51 (17.05%)	845.01k
ELEFSilver Elephant Mining Corp	$ 0.185 (-33.93%)	111.64k
WEEDCanopy Growth Corporation	$ 2.90 (-27.32%)	4.89M
XLYAuxly Cannabis Group Inc	$ 0.055 (-15.38%)	6.8M
MUXMcEwen Mining Inc	$ 10.54 (-15.00%)	249.71k
GRCGold Springs Resource Corp	$ 0.06 (-14.29%)	60k
CTSConverge Technology Solutions Corp	$ 5.42 (53.54%)	14.22M
MFCManulife Financial Corporation	$ 43.06 (0.35%)	10.83M
ENBEnbridge Inc	$ 63.52 (0.17%)	10.13M
GLOGlobal Atomic Corporation	$ 0.47 (-11.32%)	9.24M
SUSuncor Energy Inc	$ 55.35 (0.65%)	9.02M